Raymond J Lynch1, Rebecca Zhang, Rachel E Patzer, Christian P Larsen, Andrew B Adams. 1. *Division of Transplantation, Department of Surgery, Emory University School of Medicine, Atlanta, GA†Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, GA‡Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
Abstract
OBJECTIVE: To determine whether fitness for transplant can be determined by candidates' hospitalizations although waitlisted. BACKGROUND: Renal transplantation must increasingly serve a population of multiply comorbid patients in an environment defined by organ scarcity and premiums on value-based care. Determining those at excess risk for transplant is critical to these imperatives. METHODS: United States Renal Data Systems patient and claims data for all adult renal transplant recipients between 2000 and 2010 with continuous primary Medicare coverage for 1 year before and after transplantation were examined. Outcomes included readmissions within the first-year post-transplant and 3-year graft and patient survival. Chi-square statistics, Kaplan-Meier methods (log-rank test), and goodness of fit calculations (c-statistics) were performed for models of transplant outcome. RESULTS: Among 37,623 patients, the percentages of patients admitted for 0, 1 to 7, 8 to 14, or 15 or more days in the pretransplant year were 51%, 25%, 11%, and 13%. Overall readmission-free survival at 1 year was 31%. Heavily preadmitted patients were more likely to have a greater length of stay during their transplant admission, and had a greater service needs at discharge. Pretransplant admission strongly predicted more frequent post-transplant admission. Among all factors studied, preadmission was the strongest predictor of post-transplant death, and had a dose-dependent effect on both death and graft loss. CONCLUSIONS: In summary, hospitalization in the year before transplant is an objective, readily ascertainable, and powerful predictor of excess resource utilization and inferior outcome. Incorporation of a rolling assessment of patient hospitalization has potential policy implications for maximizing value in renal transplantation.
OBJECTIVE: To determine whether fitness for transplant can be determined by candidates' hospitalizations although waitlisted. BACKGROUND: Renal transplantation must increasingly serve a population of multiply comorbid patients in an environment defined by organ scarcity and premiums on value-based care. Determining those at excess risk for transplant is critical to these imperatives. METHODS: United States Renal Data Systems patient and claims data for all adult renal transplant recipients between 2000 and 2010 with continuous primary Medicare coverage for 1 year before and after transplantation were examined. Outcomes included readmissions within the first-year post-transplant and 3-year graft and patient survival. Chi-square statistics, Kaplan-Meier methods (log-rank test), and goodness of fit calculations (c-statistics) were performed for models of transplant outcome. RESULTS: Among 37,623 patients, the percentages of patients admitted for 0, 1 to 7, 8 to 14, or 15 or more days in the pretransplant year were 51%, 25%, 11%, and 13%. Overall readmission-free survival at 1 year was 31%. Heavily preadmitted patients were more likely to have a greater length of stay during their transplant admission, and had a greater service needs at discharge. Pretransplant admission strongly predicted more frequent post-transplant admission. Among all factors studied, preadmission was the strongest predictor of post-transplant death, and had a dose-dependent effect on both death and graft loss. CONCLUSIONS: In summary, hospitalization in the year before transplant is an objective, readily ascertainable, and powerful predictor of excess resource utilization and inferior outcome. Incorporation of a rolling assessment of patient hospitalization has potential policy implications for maximizing value in renal transplantation.
Authors: Kira L Newman; Raymond J Lynch; Andrew B Adams; Rebecca Zhang; Stephen O Pastan; Rachel E Patzer Journal: Transplantation Date: 2017-12 Impact factor: 4.939
Authors: Meera N Harhay; Maya K Rao; Kenneth J Woodside; Kirsten L Johansen; Krista L Lentine; Stefan G Tullius; Ronald F Parsons; Tarek Alhamad; Joseph Berger; XingXing S Cheng; Jaqueline Lappin; Raymond Lynch; Sandesh Parajuli; Jane C Tan; Dorry L Segev; Bruce Kaplan; Jon Kobashigawa; Darshana M Dadhania; Mara A McAdams-DeMarco Journal: Nephrol Dial Transplant Date: 2020-07-01 Impact factor: 5.992
Authors: Kira L Newman; Stacey A Fedewa; Melanie H Jacobson; Andrew B Adams; Rebecca Zhang; Stephen O Pastan; Rachel E Patzer Journal: Transplantation Date: 2016-12 Impact factor: 4.939
Authors: Michelle C Nguyen; Christina L Avila; Guy N Brock; Jason A Benedict; Iyore James; Ashraf El-Hinnawi; Amer Rajab; Elmahdi Elkhammas; Ronald P Pelletier; Mitchell Henry; Ginny L Bumgardner Journal: Clin Transplant Date: 2020-03-02 Impact factor: 3.456
Authors: Julien Hogan; Michael D Arenson; Sandesh M Adhikary; Kevin Li; Xingyu Zhang; Rebecca Zhang; Jeffrey N Valdez; Raymond J Lynch; Jimeng Sun; Andrew B Adams; Rachel E Patzer Journal: Transplant Direct Date: 2019-07-29
Authors: María José Pérez-Sáez; Carlos E Arias-Cabrales; Vanesa Dávalos-Yerovi; Dolores Redondo; Anna Faura; María Vera; Anna Bach; Guillermo Pedreira; Ernestina Junyent; Marta Crespo; Ester Marco; Leocadio Rodríguez-Mañas; Julio Pascual Journal: Clin Kidney J Date: 2021-07-10
Authors: María José Pérez-Sáez; Dolores Redondo-Pachón; Carlos E Arias-Cabrales; Anna Faura; Anna Bach; Anna Buxeda; Carla Burballa; Ernestina Junyent; Marta Crespo; Ester Marco; Leocadio Rodríguez-Mañas; Julio Pascual Journal: J Clin Med Date: 2022-01-28 Impact factor: 4.241
Authors: Hatem Ali; Karim Soliman; Mahmoud M Mohamed; Manzur Rahman; Johann Herberth; Tibor Fülöp; Ingi Elsayed Journal: Ann Med Date: 2021-12 Impact factor: 4.709